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Abstract
Background—Despite extensive data on health-related quality of life (HRQOL) among cancer
survivors, we do not yet have an estimate of the percent of survivors with poor mental and
physical HRQOL compared to population norms. HRQOL population means for adult-onset
cancer survivors of all ages and across the survivorship trajectory also have not been published.
Methods—Survivors (n=1,822) and adults with no cancer history (n=24,804) were identified
from the 2010 National Health Interview Survey. The PROMIS® Global Health Scale was used to
assess HRQOL. Poor HRQOL was defined as one standard deviation or more below the PROMIS
population norm.
Results—Poor physical and mental HRQOL were reported by 24.5% and 10.1% of survivors,
respectively, compared to 10.2% and 5.9% of adults without cancer (both p<.0001). This
represents a population of approximately 3.3 million and 1.4 million US survivors with poor
physical and mental HRQOL. Adjusted mean mental and physical HRQOL scores were similar for
breast, prostate, and melanoma survivors compared to adults without cancer. Survivors of cervical,
colorectal, hematologic, short-survival, and other cancers had worse physical HRQOL; cervical
and short-survival cancer survivors reported worse mental HRQOL.
Conclusion—These data elucidate the burden of cancer diagnosis and treatment among US
survivors and can be used to monitor the impact of national efforts to improve survivorship care
and outcomes.
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Impact—We present novel data on the number of US survivors with poor HRQOL. Interventions
for high-risk groups that can be easily implemented are needed to improve survivor health at a
population level.
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Introduction
The remarkable progress made in the past few decades in early detection and effective
treatment of cancer is leading to a steady increase in the number of long term cancer
survivors. Cancer incidence declined by approximately 1% per year during the period
between 2003 – 2007, while cancer mortality has been slowly declining since the 1990s(1).
The result is that there are now an estimated 12.6 million cancer survivors in the United
States alone, and these figures are expected to continue rising largely due to the aging of the
population(2). While many survivors report good health-related quality of life (HRQOL)
after cancer, there appears to be a vulnerable subgroup of the survivor population that
continues to experience poor HRQOL. It is critical to quantify the variation of cancer’s
impact on survivors’ HRQOL if we are to understand the true burden of cancer on the
population and, importantly, measure the effect of cancer control efforts on optimizing the
health and well-being of cancer survivors(3). Understanding the risk factors associated with
below-population-average, or poor, HRQOL will help identify these individuals and aid in
planning interventions for this group.
Previous research suggests that cancer survivors, relative to those without a cancer history,
have poorer HRQOL on average. In particular, survivors report more functional
impairment(4, 5), poorer health(5–7), greater psychological distress(8), and more mental
health needs(9). While older age and greater likelihood of co-morbid conditions exhibited by
survivors contribute to these differences, studies that match individuals with and without
cancer history on these factors also find decreased HRQOL among cancer patients (10).
Importantly, many of the prior population-based HRQOL studies conducted among
survivors utilized sources such as the Medicare Health Outcomes Survey that were restricted
to Medicare beneficiaries 65 years of age and older (e.g.,10, 11), while others have lacked a
comprehensive HRQOL measure(e.g.,7, 9).
Identifying who in the survivor population is at risk for poor HRQOL and the associated risk
factors for this status are important first steps in efforts to develop and appropriately target
interventions with the potential to reduce the individual and social burden of cancer. The
current study used a US population-based sample to: 1) compare the physical and mental
HRQOL of cancer survivors to those without a cancer history by examining means and
estimating the proportion who experience poor or below population-average physical and
mental HRQOL; and 2) identify the general and cancer-specific characteristics that may put
survivors at risk for experiencing poor physical and mental functioning.
Methods
Participants
Data came from the 2010 National Health Interview Survey (NHIS)(12), an annual, in
person, nationwide survey that tracks trends in illness and disability in the United States.
The NHIS utilizes a complex sampling framework involving clustering, stratification, and
multistage sampling to derive a representative sample of the civilian, non-institutionalized
population. Blacks, Hispanics, and Asians are oversampled. Data are collected by trained
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census interviewers during household interviews using computer-assisted personal
interviewing (CAPI). One adult per family was randomly chosen to complete the Sample
Adult questionnaire which contained the Cancer Control Supplement. The Cancer Control
Supplement, developed and co-funded by the National Cancer Institute and the Centers for
Disease Control and Prevention, is fielded approximately every five years and includes
questions on cancer risk factors, health behaviors, cancer screening, and cancer survivorship.
The 2010 NHIS sample included 27,157 persons 18 years of age and older for the Sample
Adult survey; the overall response rate was 60.8%. Data for the current analysis were drawn
from the Person, Sample Adult, and Cancer Control Supplement files(12).
Measures
Demographic and disease variables—Sociodemographic variables included self-
reported age, education (classified as <high school, high school or GED, some college or 2
year degree, or ≥4 year degree), race/ethnicity (non-Hispanic white, non-Hispanic black,
Hispanic, Asian, or other), marital status (married or living with a partner vs others), sex,
poverty status (defined relative to the poverty index using the NHIS imputed files(13)-
<100%, 100–199%, 200–399%, and ≥400%), and employment status (full-time, part-time,
retired, or not currently employed). In multivariate analyses we chose to use education rather
than poverty status because of significant collinearity between these predictors (X2 p-value=
<.0001). The Sample Adult file contained information on self-reported cancer history
(including site and age at diagnosis), as well as other comorbid health conditions. We
grouped hematologic malignancies (leukemias, lymphomas, and other blood cancers), as
well as cancers with a short survival time (esophagus, liver, lung, pancreas, and stomach) to
create categories for most recent cancer type. As in prior studies, short-survival cancers were
defined as those with a 5-year relative survival of less than 25%(5). For analyses including
only cancer survivors, we used breast cancer as the reference group since the quality of life
of these survivors has been well characterized in the research literature. Time since cancer
diagnosis was calculated by subtracting age at first cancer diagnosis from the participant’s
age at interview. A small number of individuals (n= 54) possibly misunderstood the age at
cancer diagnosis question and reported cancer types and corresponding ages that were
extremely unlikely (e.g., prostate cancer at the age of 3). Following the methodology of
Yabroff and colleagues(5), we considered the time since diagnosis and cancer site to be
missing for these cases. Adults who reported a history of cancer were also asked about
current treatment status (in active treatment, received treatment in the last 12 months
[recent], no current or recent treatment), types of treatments received for the most recent
cancer (surgery, radiation, chemotherapy, hormonal and bone marrow/stem cell transplant
treatments), and cancer recurrence. We examined the prevalence of ever being diagnosed
with non-cancer comorbid health conditions (hypertension, heart disease, stroke, diabetes,
lung disease), using definitions from previous NHIS research(5, 14). We defined heart
disease as reporting coronary heart disease, angina, myocardial infarction, or any other heart
condition. Lung disease included chronic bronchitis, emphysema, and current asthma. We
added arthritis to the comorbidities because of its important impact on health-related quality
of life. We summed the comorbidities for use in multivariate modeling.
Health-related quality of life (HRQOL)—The 10-item Patient-Reported Outcomes
Measurement Information System® (PROMIS®) Global Health Scale (PROMIS Global 10)
was used to assess key HRQOL domains including pain, fatigue, mental health, physical
health, social health, and overall health. Prior psychometric work suggests the presence of
two 4-item factors: global physical health (overall physical health, physical functioning,
pain, and fatigue) and global mental health (quality of life, mental health, satisfaction with
social activities, and emotional problems)(15). The general health and satisfaction with
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social roles items were examined as single items, as were the pain and fatigue items because
these are important symptoms among long-term cancer survivors. The physical and mental
health summary scores were scored according to PROMIS instructions (16) and transformed
to T-score distributions with a mean of 50 and a standard deviation of 10. The PROMIS T-
score metric was set based on a sample that is representative of the US adult population(17).
Higher PROMIS scores represent better HRQOL.
Analytic Plan
We conducted weighted analyses using SUDAAN (Version 9) to account for the unequal
probability of selection resulting from the complex survey design of the NHIS. The
incorporation of sampling weights is necessary to avoid biased estimates of model
parameters and variances. First, we examined mean HRQOL outcomes for adults without
cancer and cancer survivors (stratified by most recent cancer type), in both unadjusted and
adjusted ordinary least squares regression models including sociodemographic and health
characteristics (age, sex, race/ethnicity, education, marital status, and non-cancer
comorbidities). We also examined time since most recent cancer diagnosis as a predictor of
HRQOL, combining across cancer types. Survivors ≤ 1 year, 2–5 years, 6–10 years, and 11+
years were compared to adults without cancer in both unadjusted and adjusted models to
assess HRQOL impact across the cancer trajectory.
Next, we calculated population estimates for the proportion of survivors and adults without
cancer that report PROMIS mental and physical health HRQOL scores more than one
standard deviation below the population mean of 50 (PROMIS T-score <40). Standardized
values for clinically important differences have not yet been identified for the PROMIS
summary scales, so we chose to use the conservative one standard deviation criterion which
is commonly used as a definition for impairment in functioning. This standard would be
expected to identify the 15% of individuals in the population with the worst HRQOL.
Population estimates for the number of US cancer survivors with poor HRQOL were
calculated by multiplying the proportion of the population by the sum of the population
weights.
Finally, we also examined multivariable logistic regression models stratified by cancer
history with poor HRQOL (defined as a PROMIS score <40) as the outcome. Age, race/
ethnicity, sex, marital status, education, number of non-cancer comorbidities were included
as covariates for both groups; most recent cancer site, time since diagnosis, recurrence,




In the 2010 NHIS, a total of 2,333 adults reported a history of cancer. We excluded persons
who reported a history of exclusively non-melanoma skin or “unknown” skin cancers
(n=494) and those who did not answer questions about cancer type (n=17), resulting in an
analytic sample of 1,822 cancer survivors. The comparison population included 24,804
adults without a history of cancer. The percent of the total sample missing HRQOL data was
8.6%. Older persons and those with less education were more likely to be missing mental
and physical HRQOL data. Black and Asian adults were more likely to be missing mental
HRQOL data compared to non-Hispanic whites.
As found in previous analyses, adult cancer survivors were older, less likely to be racial and
ethnic minorities, more likely to be female, reported higher incomes, and had more non-
cancer comorbidities compared to adults without a history of cancer (see Table 1). Cancer
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specific characteristics of survivors are shown in Table 2. Almost 12% of the survivors
reported that they had a recurrence of their cancer.
Health-Related Quality of Life in Survivors and Individuals without a History of Cancer
In unadjusted models (shown in Supplementary Table S1), the overall effect of both cancer
site and time since last cancer diagnosis was statistically significant for all HRQOL
outcomes. In multivariate adjusted models, most recent cancer type was a significant
predictor of HRQOL outcomes (see Table 3); time since most recent cancer diagnosis was
significantly associated with only physical, general health, fatigue, and pain HRQOL.
Breast, prostate, and melanoma cancer survivors had HRQOL estimated marginal means
that were not statistically different from or exceeded those of adults without a history of
cancer. In contrast, survivors of colorectal, cervical, hematologic, short-survival, and “other”
cancers had significantly poorer physical HRQOL and fatigue compared to adults without
cancer (all p <.05). Survivors of cervical and short-survival cancers also reported
significantly poorer mental HRQOL and general health. Worse pain was reported by
survivors of cervical, hematologic, and “other” malignancies.
In multivariate adjusted models, the overall effect of time since diagnosis (with adults
without cancer as a comparison group) was significant for physical HRQOL, fatigue, pain,
and general health, but not mental HRQOL or satisfaction with social functioning (see Table
3). Survivors who were less than 2 years from their most recent cancer diagnosis reported
lower physical HRQOL, fatigue, and pain scores, but were not significantly different from
adults without cancer on mental HRQOL, general health, and satisfaction with social roles.
Survivors 2 to 5 years since their most recent cancer diagnosis reported significantly lower
physical and mental HRQOL, general health, and fatigue scores than adults without cancer.
The groups that were 6–10 and 11 years from their last cancer diagnosis reported
significantly lower physical HRQOL and fatigue scores (only for the 6–10 year survivors)
than adults without cancer.
Population Estimates for Poor HRQOL among Cancer Survivors
Approximately 24.5% of cancer survivors reported physical HRQOL more than one
standard deviation below the population mean (i.e. a T-score <40); while 10.1% reported
poor mental HRQOL (see Table 4). This represents an estimated population of
approximately 3.3 and 1.4 million US cancer survivors with poor physical and mental
HRQOL, respectively. Prevalence of poor HRQOL in adults without a history of cancer was
significantly lower compared to the survivor sample, 10.2% for physical HRQOL and 5.9%
for mental HRQOL (X2= 142.5 & 23.4, respectively, p <.0001). Seven percent of survivors,
representing a population of almost 973,000 US adults reported both physical and mental
HRQOL <40.
Predictors of Poor HRQOL in Survivors and Adults without Cancer
Physical health—We stratified multivariate models by cancer history and adjusted for
age, sex, race/ethnicity, marital status, education, and number of comorbidities (Table 5), as
well as time since diagnosis, treatment recency, number of cancers, recurrence, and most
recent cancer site for the survivors. There was no linear trend for age category with
increasing risk for poor physical HRQOL in either survivors or adults without cancer.
Adults without cancer who were 50–64 were the only group with significantly increased risk
compared to the youngest age groups. Less education and having more than one non-cancer
comorbidity were also independently associated with poor physical HRQOL among both
groups. Females without cancer were at increased risk for poor physical HRQOL, but this
was not true among survivors. There were no significant race/ethnicity differences in
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physical HRQOL among cancer survivors; among adults without cancer. Asian adults were
significantly less likely than non-Hispanic whites to report poor physical HRQOL.
Compared to survivors with breast cancer, survivors with cervical, hematologic, short-
survival, and less common “other” cancers were more likely to report poor physical
HRQOL. Survivors of prostate cancer were significantly less likely to report poor physical
HRQOL. Neither cancer recurrence, nor time since most recent cancer diagnosis was a
significant predictor of poor physical HRQOL. Survivors currently receiving cancer
treatment (excluding maintenance hormonal therapies) were significantly more likely to
report poor physical HRQOL compared to survivors who did not receive treatment in the
past 12 months. Survivors with more than one cancer diagnosis were not more likely to
report poor physical HRQOL.
Mental health—Younger, unmarried, less educated, and persons with more non-cancer
comorbidities were at greater risk for poor mental HRQOL in both the cancer survivor and
general adult populations. Hispanic and Asian adults without cancer were less likely than
non-Hispanic whites to report poor mental HRQOL; there were no race/ethnicity differences
among cancer survivors.
There were few site differences among cancer survivors. Compared to survivors with breast
cancer, only survivors with short-survival cancers were significantly more likely to have
poor mental HRQOL. Survivors with a recurrence were more likely to report poor mental
HRQOL. Neither time since diagnosis nor treatment recency was associated with likelihood
of poor HRQOL. Surprisingly, survivors with multiple cancers were significantly less likely
to report poor mental HRQOL.
Discussion
Overall, these data suggest resilience among many long-term survivors. In general we found
that after adjustment for sociodemographic differences, long-term survivors of many of the
most common cancers in the survivor population (breast, prostate, and melanoma) were
doing as well or better than adults without a history of cancer. However, not all survivors
report they are thriving. This study adds to the literature on HRQOL after cancer by
specifying that 25% and 10% of cancer survivors report poor physical and mental HRQOL,
respectively compared to only 10% and 6% of the adults without cancer. We estimate that
more than 3.6 million cancer survivors report mental and/or physical HRQOL more than one
standard deviation below the population mean.
The higher rates of poor HRQOL among cancer survivors observed in this study are
consistent with findings suggesting higher prevalence of poor physical and mental health
outcomes among survivors relative to adults without cancer (8, 18, 19). Predictors of poor
mental and physical HRQOL identified in this study, such as lower socioeconomic status
and a greater number of non-cancer comorbidities, have also been identified in prior
population and clinic-based samples (11, 20). Younger current age was also a correlate of
poor mental health, consistent with prior research (19, 21). Interventions to promote well-
being among vulnerable populations of survivors are needed to improve HRQOL at a
population level. For example, both cognitive behavioral therapy and physical activity
interventions have been shown to improve physical and mental health quality of life in
cancer survivors (22–24). The increasing availability of these kinds of interventions via
telephone (25, 26) or internet (27, 28) platforms will increase the scalability and reach of
effective interventions. Given the very high prevalence of non-cancer comorbidities in this
population, as well as the importance of comorbidities on HRQOL, it is essential to address
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both prevalent comorbid disease, as well as risk factors for poor health as a part of
comprehensive cancer-related follow-up care.
In contrast to other population-based studies of cancer survivors (29, 30), we did not observe
any race/ethnicity differences in mental or physical HRQOL among the cancer survivor
sample. There is considerable heterogeneity in the research literature regarding racial and
ethnic difference in HRQOL after cancer (for review see 31). Differences in the HRQOL
measures used, as well as the sample characteristics (e.g., single cancer site vs multiple
cancers, population-based vs clinic samples), may account for the different findings. It is
possible that disease-specific measures of HRQOL may be more sensitive to racial/ethnic
differences in the experience of cancer.
In addition, our finding regarding the lower risk for poor mental health among survivors
with multiple cancers contrasts with recent population studies reporting worse physical and
mental health outcomes for survivors of multiple cancers, compared to survivors with a
single primary cancer (32, 33). This difference may be due to the specific outcomes
examined (HRQOL vs mental distress, comorbidities, and disability) or the analytic strategy
used for describing the effect. Burris & Andrykowski (32, 33) treated multiple cancers as a
distinct group, comparing them to both single primary survivors and no-cancer controls. In
contrast, we used single/multiple cancers as a covariate in multiple regression models that
also controlled for site of most recent cancer diagnosis.
Interestingly, the PROMIS® Global Health Scale scores in our sample were somewhat
higher than those observed in the PROMIS® validation sample(34). We observed an
unadjusted mean of 53.3 and 53.9 for physical and mental health respectively in our adults
without cancer compared to 49.8 and 49.0 in the overall validation sample. In addition the
unadjusted means for our cancer survivors were higher than those reported for the cancer
subgroup of the PROMIS® validation sample (47.3 for mental and 43.6 for physical). We
also observed that a smaller proportion of our participants had scores that were one standard
deviation below the population mean than would be expected based on comparison to the
normal curve. It is difficult to explain the observed differences because both the PROMIS®
validation and NHIS samples were weighted to reflect 2000 U.S. Census data. There were
differences in both the sampling strategy and mode of PROMI® data collection. The
PROMIS® validation sample used a commercial internet polling panel (17), whereas NHIS
data are collected in-person by trained census workers using a geographic sampling strategy.
Prior studies have suggested that telephone administration tends to yield more positive
HRQOL scores compared to mail completion(35), and in-person administration as used in
NHIS may have a similar effect. Ongoing studies of PROMIS® are collecting population-
based data on cancer survivors with the goal to estimate population norms for cancer
survivors.
Limitations of this study include the lack of recommended cut points for clinically
significant impairments or minimally important differences in HRQOL. Further work will
be needed to confirm the clinical significance of various cut points for the PROMISR Global
10 items. Further, because of the large number of cancer sites included in this study and the
heterogeneity in treatments received by cancer site, we were unable to examine treatment
influences on HRQOL. Site-specific studies are more appropriate to answer the important
question of how treatment influences long-term HRQOL, particularly if they include cancer-
specific measures of HRQOL. As a generic HRQOL measure, the PROMIS® Global 10 is
suitable to compare survivors to other adults, but may not fully capture all domains of
HRQOL relevant to cancer, such as sexual functioning. In addition, all data, including
cancer history, were based on self-report. Although prior studies have suggested that there is
good concordance between self-reported cancer and registry or medical record confirmed
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cases, misreporting may be a particular concern for male survivors(36) and women with
endometrial and cervical cancers(36, 37). Our cancer survivor sample was 58% female
compared with 54% female reported in the NCI SEER complete prevalence estimate(1)
which may be evidence of under-reporting by males. Participants may also have had a hard
time distinguishing between recurrence (either local or distal) and second cancers and
between invasive cancer and precancerous conditions like cervical dysplasia. Finally, the
NHIS did not include cancer survivors living in institutions such as nursing homes or those
too ill to participate who may have had worse HRQOL.
In conclusion, we present unique data on the HRQOL of long-term cancer survivors in the
US and the proportion and number with self-reported levels of HRQOL that may be of
clinical concern. This study builds on prior research by examining the prevalence of poor
HRQOL, rather than just average HRQOL scores, in a population-based sample of US
cancer survivors that includes both younger and older survivors. Cancer survivors were
significantly more likely than adults without cancer to report poor HRQOL, with 24.5%
reporting poor physical HRQOL and 10.1% reported poor mental HRQOL. Most
concerningly, 7.2% of survivors reported both poor mental and physical HRQOL. These
data are useful for comparing the representativeness of other clinic and state-based samples,
identifying potentially vulnerable populations of survivors for clinic and public health
interventions, guiding the implementation of plans for survivorship care with the potential to
improve HRQOL, and determining progress towards national goals of enhancing life after
cancer for the growing population of cancer survivors.
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Table 2
Cancer Related Characteristics of Survivors in the 2010 National Health Interview Survey(n=1,822)
Raw N Weighted %





Hematologic Malignancies 106 6.6








Ever had a recurrence Yes 185 11.8
No 1463 88.2
Treatment Status Current 109 6.3
Within the past 12 months 154 9.5
Not in the past 12 months 1389 84.2
Number of Cancers 1 1633 89.6
≥2 189 10.4
Treatments Received (% Yes) Surgery 1145 69.8
Radiation 449 26.8
Chemotherapy 422 25.6
Hormonal Therapy 113 7.0
Bone Marrow/Stem Cell Transplant 8 0.5
None 98 5.9
Numbers may not sum to 1,822 due to missing data for some variables.
#
Last cancer site “unknown” was either due to multiple cancers diagnosed in the same calendar year or missing data on year of diagnosis for one or
more reported cancers.
¥
54 cases were defined as missing on cancer site and time since diagnosis due to improbable combinations of cancer site and age at diagnosis.
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Table 4
Population Estimates for Poor Health-Related Quality of Life among Cancer Survivors from the 2010 National








Physical Health Score < 1 SD below US Population
Mean
10.2% 24.5% 3,278,000(184,000)
Mental Health Score < 1 SD below US Population
Mean
5.9% 10.1% 1,356,000 (122,000)
Physical and Mental HRQOL < 1 SD below US
Population Mean
3.5% 7.2% 973,000 (99,000)
1 SD score below pop mean = 40 on the PROMIS T-score metric. The comparison between survivors and adults without cancer is statistically
significant for all comparisons (p<.0001)
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